Brittle diabetes describes diabetes that is extremely difficult to control, with blood sugar levels swinging unpredictably between dangerous highs and lows. It isn’t an official medical diagnosis but rather a term doctors use to flag cases where standard management isn’t working and the instability is disrupting a person’s daily life. You may also hear it called labile diabetes or unstable diabetes. The term dates back to 1934, and while definitions have shifted over the decades, the core idea remains the same: blood sugar that resists predictable management despite reasonable effort.
Brittle diabetes is uncommon. A British study found it affects roughly 1 in 1,000 diabetic patients overall, or about 3 in 1,000 among those who take insulin. But for the people living with it, the condition carries serious medical risks and a heavy psychological toll.
What Makes Blood Sugar So Unstable
In most cases, brittle diabetes doesn’t have a single cause. Several overlapping problems can make glucose levels behave erratically, and identifying the right combination is often part of the challenge.
Gastroparesis is one of the most common culprits. This is a condition where the stomach empties food more slowly than normal, a complication that develops in some people with longstanding diabetes. Because carbohydrate absorption depends heavily on how fast food leaves the stomach, delayed emptying throws off the timing of insulin. You take insulin expecting food to hit your bloodstream at a certain pace, but the stomach holds onto it longer than expected, so blood sugar drops first, then spikes later when the food finally absorbs. Worse, high blood sugar itself slows gastric emptying further, creating a feedback loop that amplifies the swings.
Hypoglycemia unawareness adds another layer of danger. Normally your body sends warning signs when blood sugar drops too low: shakiness, sweating, a racing heart. But roughly 25% of people with type 1 diabetes lose those warning signals over time, especially after repeated low episodes. Without those early alerts, blood sugar can plummet to levels that cause confusion, seizures, or unconsciousness before the person realizes anything is wrong. People on insulin commonly experience low blood sugar multiple times a week, and for those who can’t feel it coming, even routine activities like driving become risky.
Hormonal fluctuations, stress, infections, inconsistent absorption of injected insulin, and certain medications can all contribute as well. In some people, the underlying biology simply makes glucose levels more reactive than average, and no amount of careful management fully smooths them out.
How It Differs From Ordinary Diabetes
Everyone with diabetes has occasional blood sugar spikes or dips. What sets brittle diabetes apart is the severity, frequency, and unpredictability of those swings. People with brittle diabetes may cycle between dangerously high blood sugar (sometimes progressing to diabetic ketoacidosis, a medical emergency) and dangerously low blood sugar within the same day, despite following their treatment plan carefully.
This often leads to repeated emergency room visits and hospitalizations. The pattern itself is part of how clinicians recognize brittle diabetes: recurrent episodes of ketoacidosis or severe hypoglycemia that can’t be explained by obvious factors like missed insulin doses or dietary lapses. It’s the “unexplained” part that distinguishes it. The blood sugar swings seem to have a life of their own.
The Daily Burden
Living with brittle diabetes means constant vigilance with unpredictable rewards. You can do everything right, count carbohydrates precisely, dose insulin carefully, and still end up with a blood sugar reading that makes no sense. Over time, that erodes confidence in your ability to manage the condition. Many people describe a cycle of anxiety, frustration, and exhaustion that some clinicians refer to as diabetes burnout.
The physical risks compound the emotional strain. A severe hypoglycemic episode raises the risk of heart attack or stroke in the following year. Recurrent lows can also affect brain function and memory over time. The fear of losing consciousness, whether at work, while driving, or during sleep, reshapes how people plan their days and limits their independence.
Managing Unpredictable Swings
For many people with brittle diabetes, continuous glucose monitors are the single most impactful tool. These small sensors, worn on the skin, check blood sugar every few minutes and send alerts when levels are trending too high or too low. They’re especially valuable for people with hypoglycemia unawareness because the device catches drops the body no longer signals on its own.
Automated insulin delivery systems, sometimes called closed-loop pumps, take this a step further. They pair a continuous glucose monitor with an insulin pump that adjusts dosing automatically based on real-time readings. Meta-analyses of these systems show they increase the time people spend in a safe blood sugar range while keeping dangerous lows rare. For someone whose glucose swings have been impossible to predict, handing some of the decision-making to an algorithm can reduce both the medical risk and the mental load.
The general goal for most people with diabetes is to keep blood sugar between 70 and 180 mg/dL for at least 70% of the day, roughly 17 hours. For older adults or those at high risk of complications, the target relaxes to above 50% of the day, or about 12 hours, with less than 15 minutes spent below 70 mg/dL. People with brittle diabetes often fall well short of these targets, but the numbers give both patient and clinician a concrete way to measure whether a new approach is helping.
When Standard Treatment Isn’t Enough
For the most severe cases, particularly people with type 1 diabetes who experience life-threatening hypoglycemia despite optimized technology, islet cell transplantation is an option. Islet cells are the insulin-producing cells from a donor pancreas. They’re infused into the liver, where they begin sensing blood sugar and releasing insulin on their own.
The results are striking. A Phase 3 trial sponsored by the National Institutes of Health found the procedure worked in 80% to 90% of patients across eight North American centers. It virtually eliminated life-threatening hypoglycemia at one and two years after transplant. In one long-running program, nearly half the patients remained completely free of insulin injections for more than five years, and the first patient treated went over 14 years without needing insulin. The trial showed islet transplantation outperformed intensive insulin therapy on every measure: quality of life, blood sugar control, and frequency of severe low episodes.
The trade-off is that transplant recipients typically need long-term immune-suppressing medications to prevent their body from rejecting the donor cells, which carries its own health risks. Access also remains limited. But for people whose daily life is dominated by dangerous, unpredictable blood sugar swings, the procedure represents one of the most effective interventions currently available.